Reinfusate Heparin Concentrations Produced by Two Autotransfusion Systems

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 31, Issue 1, 2017, Pages 90-98

  Buys, Willem Frederik ^a   Buys, Mathilde ^a   Levin, Andrew Ian ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

autologous transfusion; autotransfusion system; cardiac surgery; cell saver; heparin concentration; reinfusate

Indexed keywords

HEPARIN; ANTICOAGULANT AGENT;

ADULT; ARTICLE; AUTOTRANSFUSION SYSTEM; BLOOD AUTOTRANSFUSION; BLOOD BANK; BLOOD SALVAGE; CLINICAL ASSESSMENT; CONCENTRATION PROCESS; DRUG INFUSION; FEMALE; HEART SURGERY; HEMATOLOGY EQUIPMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; BLOOD; CARDIOPULMONARY BYPASS; DEVICES; MIDDLE AGED; PROCEDURES;

ADULT; ANTICOAGULANTS; BLOOD TRANSFUSION, AUTOLOGOUS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; OPERATIVE BLOOD SALVAGE; POSTOPERATIVE CARE; PROSPECTIVE STUDIES;

EID: 84994176562     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2016.06.014     Document Type: Article

References (63)

1. 1 Ferraris, V.A., Brown, J.R., Despotis, G.J., et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 91 (2011), 944–982.
2. 2 Spiess, B.D., Red cell transfusions and guidelines: A work in progress. Hematol Oncol Clin North Am 21 (2007), 185–200.
3. 3 Carless, P.A., Henry, D.A., Moxey, A.J., et al. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Re, 2010 CD001888.
4. 4 Ashworth, A., Klein, A.A., Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth 105 (2010), 401–416.
5. 5 Surgenor, S.D., Kramer, R.S., Olmstead, E.M., et al. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 108 (2009), 1741–1746.
6. 6 Engoren, M.C., Habib, R.H., Zacharias, A., et al. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 74 (2002), 1180–1186.
7. 7 Weintraub, W.S., Jones, E.L., Craver, J.M., et al. In-hospital and long-term outcome after reoperative coronary artery bypass graft surgery. Circulation 92 (1995), 1150–1157.
8. 8 Koch, C.G., Li, L., Duncan, A.I., et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 81 (2006), 1650–1657.
9. 9 DeRose, J.J. Jr, Toumpoulis, I.K., Balaram, S.K., et al. Preoperative prediction of long-term survival after coronary artery bypass grafting in patients with low left ventricular ejection fraction. J Thorac Cardiovasc Surg 129 (2005), 314–321.
10. 10 Ridler, B.M.F., Thompson, J.F., The qualities of blood reinfused during cell salvage. Transfus Altern. Transfus Med 5 (2003), 466–471.
11. 11 Vonk, A.B., Meesters, M.I., Garnier, R.P., et al. Intraoperative cell salvage is associated with reduced postoperative blood loss and transfusion requirements in cardiac surgery: A cohort study. Transfusion (Paris) 53 (2013), 2782–2789.
12. 12 Wang, G., Bainbridge, D., Martin, J., et al. The efficacy of an intraoperative cell saver during cardiac surgery: A meta-analysis of randomized trials. Anesth Analg 109 (2009), 320–330.
13. 13 Djaiani, G., Fedorko, L., Borger, M.A., et al. Continuous-flow cell saver reduces cognitive decline in elderly patients after coronary bypass surgery. Circulation 116 (2007), 1888–1895.
14. 14 Despotis, G.J., Filos, K.S., Zoys, T.N., et al. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: A multivariate analysis in cardiac surgical patients. Anesth Analg 82 (1996), 13–21.
15. 15 Sharma, A.D., Al-Achi, A., Seccombe, J.F., et al. Does incorporation of thromboelastography improve bleeding prediction following adult cardiac surgery?. Blood Coagul Fibrinolysis 25 (2014), 561–570.
16. 16 Rubens, F.D., Boodhwani, M., Mesana, T., et al. The cardiotomy trial: A randomized, double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function. Circulation 116 (2007), I89–I97.
17. 17 American Association of Blood Banks. Guidance for Standards for Perioperative Autologous Blood Collection and Administration, 1st ed, 2002, American Association of Blood Banks, Bethesda, MD.
18. 18 Levy, F., Mettauer, B., Gros, H., et al. Quality of reinfused blood cells and plasma in cardiac surgery after washing with the new Electa 5.0 Cell Separator. Anesthesiology, 95, 2001, A513.
19. 19 Overdevest, E.P., Lanen, P.W., Feron, J.C., et al. Clinical evaluation of the Sorin Xtra(R) Autotransfusion System. Perfusion 27 (2012), 278–283.
20. 20 Electa instructions for use. Dideco, Italy. 2003.
21. 21 Sorin Xtra operator's manual. Sorin, Mirandola, Italy. 2007.
22. 22 Funk, D.M., Coagulation assays and anticoagulant monitoring. Hematology Am Soc Hematol Educ Program 2012 (2012), 460–465.
23. 23 de Agostini, A.I., Dong, J.C., de Vantery Arrighi, C., et al. Human follicular fluid heparin sulfate contains abundant 3-O-sulfated chains with anticoagulant activity. J Biol Chem 283 (2008), 28115–28124.
24. 24 Coulter, B., HemosIL Heparin Kit [package insert]. 2007, Fullerton, California.
25. 25 Altman, D.G., Machin, D., Bryant, T.N., Gardner, M.J., (eds.) Statistics With Confidence, 2nd ed, 2000, BMJ Books, London, England.
26. 26 Umlas, J., O'Neill, T.P., Heparin removal in an autotransfusor device. Transfusion (Paris) 21 (1981), 70–73.
27. 27 Ottesen, S., Froysaker, T., Use of haemonetics cell saver for autotransfusion in cardiovascular surgery. Scand J Thorac Cardiovasc Surg 16 (1982), 263–268.
28. 28 Paravicini, D., Schmitz-Huebner, U., Stinnesbeck, B., [Heparin elimination in intraoperative autotransfusion with the haemonetics cell saver]. Infusionsther Klin Ernahr 10 (1983), 19–21.
29. 29 Sandmann, W., Bruster, H., Vossberg, H., et al. [Autotransfusion in aneurysm surgery]. Langenbecks Arch Chir 366 (1985), 353–358.
30. 30 McShane, A.J., Power, C., Jackson, J.F., et al. Autotransfusion: Quality of blood prepared with a red cell processing device. Br J Anaesth 59 (1987), 1035–1039.
31. 31 Kling, D., Borner, U., von Bormann, B., et al. Heparin elimination and free hemoglobin following cell separation and washing of autologous blood with Cell Saver 4 [in German]. Anasthesie, Intensivtherapie, Notfallmedizin 23 (1988), 88–90.
32. 32 Sistino, J.J., Owitz, D., Mongero, L.B., Heparin washout in the pediatric Cell Saver bowl. J Extra Corpor Technol 24 (1992), 94–96.
33. 33 Gravlee, G.P., Hopkins, M.B., Yetter, C.R., et al. Heparin content of washed red blood cells from the cardiopulmonary bypass circuit. J Cardiothorac Vasc Anesth 6 (1992), 140–142.
34. 34 Rouge, P., Fourquet, D., Depoix-Joseph, J.P., et al. Heparin removal in three intraoperative blood savers in cardiac surgery. Appl Cardiopulm Pathophysiol 5 (1993), 5–8.
35. 35 Kalra, M., Beech, M.J., al-Khaffaf, H., et al. Autotransfusion in aortic surgery: The Haemocell System 350 cell saver. Br J Surg 80 (1993), 32–35.
36. 36 Vorweg, M., Muckel, G., Knuttgen, D., et al. Heparin-induced coagulation disturbance from mechanical autotransfusion [in German]. Anaesthesist 47 (1998), 979–981.
37. 37 Geiger, P., Platow, K., Bartl, A., et al. New developments in autologous transfusion systems. Anaesthesia 53:Suppl 2 (1998), 32–35.
38. 38 Cuby, C., Levy, F., Grima, M., et al. Blood quality after concentration and washing with a new cell separator: Electa (Dideco), 2006, Congress of the European Society for Haemapheresis, Strasbourg, France.
39. 39 Burman, J.F., Westlake, A.S., Davidson, S.J., et al. Study of five cell salvage machines in coronary artery surgery. Transfus Med 12 (2002), 173–179.
40. 40 Serrick, C.J., Scholz, M., Melo, A., et al. Quality of red blood cells using autotransfusion devices: A comparative analysis. J Extra Corpor Technol 35 (2003), 28–34.
41. 41 Kelleher, A., Davidson, S., Gohil, M., et al. A quality assurance programme for cell salvage in cardiac surgery. Anaesthesia 66 (2011), 901–906.
42. 42 Yawn, D.H., Ensuring quality during intraoperative blood salvage. Laboratory Medicine 25 (1994), 626–631.
43. 43 Scrascia, G., Rotunno, C., Nanna, D., et al. Pump blood processing, salvage and re-transfusion improves hemoglobin levels after coronary artery bypass grafting, but affects coagulative and fibrinolytic systems. Perfusion 27 (2012), 270–277.
44. 44 de Jong, M., Ray, M., Crawford, S., et al. Platelet and leukocyte activation in salvaged blood and the effect of its reinfusion on the circulating blood. Clin Orthop Relat Res 456 (2007), 238–242.
45. 45 Murray, D.J., Gress, K., Weinstein, S.L., Coagulopathy after reinfusion of autologous scavenged red blood cells. Anesth Analg 75 (1992), 125–129.
46. 46 Ichikawa, J., Kodaka, M., Nishiyama, K., et al. Reappearance of circulating heparin in whole blood heparin concentration-based management does not correlate with postoperative bleeding after cardiac surgery. J Cardiothorac Vasc Anesth 28 (2014), 1003–1007.
47. 47 Glimelius, B., Busch, C., Hook, M., Binding of heparin on the surface of cultured human endothelial cells. Thromb Res 12 (1978), 773–782.
48. 48 Kesteven, P.J., Ahmed, A., Aps, C., et al. Protamine sulphate and heparin rebound following open-heart surgery. J Cardiovasc Surg (Torino) 27 (1986), 600–603.
49. 49 Spiess, B.D., Horrow, J., Kaplan, J.A., Transfusion medicine and coagulation disorders. Kaplan, J.A., Reich, D.L., Konstadt, S.N., (eds.), 2011, Cardiac Anaesthesia (The Echo Era), Elsevier, 949–991.
50. 50 Milas, B.L., Jobes, D.R., Gorman, R.C., Management of bleeding and coagulopathy after heart surgery. Semin Thorac Cardiovasc Surg 12 (2000), 326–336.
51. 51 Frick, P.G., Brogli, H., The mechansim of heparin rebound after extracorporeal circulation for open cardiac surgery. Surgery 59 (1966), 721–726.
52. 52 Gollub, S., Heparin rebound in open heart surgery. Surg Gynecol Obstet 124 (1967), 337–346.
53. 53 Ellison, N., Beatty, C.P., Blake, D.R., et al. Heparin rebound. Studies in patients and volunteers. J Thorac Cardiovasc Surg 67 (1974), 723–729.
54. 54 Kaul, T.K., Crow, M.J., Rajah, S.M., et al. Heparin administration during extracorporeal circulation: Heparin rebound and postoperative bleeding. J Thorac Cardiovasc Surg 78 (1979), 95–102.
55. 55 Fiser, W.P., Read, R.C., Wright, F.E., et al. A randomized study of beef lung and pork mucosal heparin in cardiac surgery. Ann Thorac Surg 35 (1983), 615–620.
56. 56 Guffin, A.V., Dunbar, R.W., Kaplan, J.A., et al. Successful use of a reduced dose of protamine after cardiopulmonary bypass. Anesth Analg 55 (1976), 110–113.
57. 57 American Association of Blood Banks. Guidance for Standards for Perioperative Autologous Blood Collection and Administration. 5th ed, 2013, American Association of Blood Banks, Bethesda, MD.
58. 58 American Association of Blood Banks. Guidance for Standards for Perioperative Autologous Blood Collection and Administration. 6th ed. Bethesda, MD: American Association of Blood Banks, 2014.
59. 59 Haselbach, S., Maurer, J., Vogel, V., et al. A novel method for the direct determination of heparin concentration during cardiopulmonary bypass surgery. Clin Chem Lab Med 51 (2013), 2037–2043.
60. 60 Reiner, J.S., Coyne, K.S., Lundergan, C.F., et al. Bedside monitoring of heparin therapy: Comparison of activated clotting time to activated partial thromboplastin time. Cathet Cardiovasc Diagn 32 (1994), 49–52.
61. 61 Galeone, A., Rotunno, C., Guida, P., et al. Monitoring incomplete heparin reversal and heparin rebound after cardiac surgery. J Cardiothorac Vasc Anesth. 27 (2013), 853–858.
62. 62 Taneja, R., Marwaha, G., Sinha, P., et al. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery. Can J Anaesth 56 (2009), 489–496.
63. 63 Levin, A.I., Heine, A.M., Coetzee, J.F., et al. Heparinase thromboelastography compared with activated coagulation time for protamine titration after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 28 (2014), 224–229.